Max Stanley Chartrand
Overview
Explore the profile of Max Stanley Chartrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Markov A, Thangavelu L, Aravindhan S, Zekiy A, Jarahian M, Chartrand M, et al.
Stem Cell Res Ther
. 2024 Apr;
15(1):110.
PMID: 38644488
No abstract available.
2.
Marofi F, Rahman H, Al-Obaidi Z, Turki Jalil A, Abdelbasset W, Suksatan W, et al.
Stem Cell Res Ther
. 2021 Aug;
12(1):465.
PMID: 34412685
Acute myeloid leukemia (AML) is a serious, life-threatening, and hardly curable hematological malignancy that affects the myeloid cell progenies and challenges patients of all ages but mostly occurs in adults....
3.
Marofi F, Tahmasebi S, Rahman H, Kaigorodov D, Markov A, Valerievich Yumashev A, et al.
Stem Cell Res Ther
. 2021 Aug;
12(1):443.
PMID: 34362452
No abstract available.
4.
Hassanzadeh A, Altajer A, Rahman H, Saleh M, Bokov D, Abdelbasset W, et al.
Front Cell Dev Biol
. 2021 Jul;
9:686453.
PMID: 34322483
Mesenchymal stem/stromal cell (MSC)-based therapy has become an attractive and advanced scientific research area in the context of cancer therapy. This interest is closely linked to the MSC-marked tropism for...
5.
Marofi F, Al-Awad A, Rahman H, Markov A, Abdelbasset W, Ivanovna Enina Y, et al.
Front Oncol
. 2021 Jun;
11:673276.
PMID: 34178661
The tumor microenvironment (TME) is greatly multifaceted and immune escape is an imperative attribute of tumors fostering tumor progression and metastasis. Based on reports, the restricted achievement attained by T...
6.
Marofi F, Abdul-Rasheed O, Rahman H, Setia Budi H, Turki Jalil A, Valerievich Yumashev A, et al.
Cancer Sci
. 2021 May;
112(9):3427-3436.
PMID: 34050690
Chimeric antigen receptors (CARs) have a unique facet of synthetic biology and offer a paradigm shift in personalized medicine as they can use and redirect the patient's immune cells to...
7.
Hassanzadeh A, Rahman H, Markov A, Endjun J, Zekiy A, Chartrand M, et al.
Stem Cell Res Ther
. 2021 May;
12(1):297.
PMID: 34020704
Recently, mesenchymal stem/stromal cells (MSCs) and their widespread biomedical applications have attracted great consideration from the scientific community around the world. However, reports have shown that the main populations of...
8.
Marofi F, Tahmasebi S, Rahman H, Kaigorodov D, Markov A, Valerievich Yumashev A, et al.
Stem Cell Res Ther
. 2021 Mar;
12(1):217.
PMID: 33781320
Despite many recent advances on cancer novel therapies, researchers have yet a long way to cure cancer. They have to deal with tough challenges before they can reach success. Nonetheless,...
9.
Marofi F, Rahman H, Thangavelu L, Dorofeev A, Bayas-Morejon F, Shirafkan N, et al.
Stem Cell Res Ther
. 2021 Mar;
12(1):200.
PMID: 33752707
In recent decades, a new method of cellular immunotherapy was introduced based on engineering and empowering the immune effector cells. In this type of immunotherapy, the immune effector cells are...
10.
Markov A, Thangavelu L, Aravindhan S, Zekiy A, Jarahian M, Chartrand M, et al.
Stem Cell Res Ther
. 2021 Mar;
12(1):192.
PMID: 33736695
Over recent years, mesenchymal stem/stromal cells (MSCs) and their potential biomedical applications have received much attention from the global scientific community in an increasing manner. Firstly, MSCs were successfully isolated...